# BioMArkeRs of INflammation, Infection, and Immunity in the Critical Area (MARINA): the Use of Inflammatory and Immunity Biomarkers as Early Predictors of Clinical Severity, Organ Damage, Response to Treatment, and Infectious Complications in Patients Admitted to the Critical Care Area.

> **NCT07682766** · — · RECRUITING · sponsor: **University of Turin, Italy** · enrollment: 200 (estimated)

## Conditions studied

- Septic Shock
- Immunocompromised Patients

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07682766
- **Lead sponsor:** University of Turin, Italy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07682766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07682766, "BioMArkeRs of INflammation, Infection, and Immunity in the Critical Area (MARINA): the Use of Inflammatory and Immunity Biomarkers as Early Predictors of Clinical Severity, Organ Damage, Response to Treatment, and Infectious Complications in Patients Admitted to the Critical Care Area.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07682766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*